 SALT LAKE CITY, July 13, 2021 PRNewswire -- Recursion NASDAQ: RXRX, a clinical-stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry, automation, machine learning and engineering, today announced its formation of a Therapeutics Advisory Board TAB, chaired by Joseph Miletich, MD, PhD. The TAB will guide Recursions executive team and Board of Directors on the key challenge of developing medicines at scale from its tech-enabled drug discovery pipeline and bringing them to the patients who need them the most. 